The line separating ambitious entrepreneurial optimism from criminal deception has rarely been sharper, or more perilous for startup founders. Ilit Raz, the founder and former chief executive officer of the artificial intelligence startup Joonko, recently pleaded guilty to federal securities fraud. Her case has sent shockwaves through the venture capital ecosystem, serving as a stark reminder of the severe personal consequences that await executives who fabricate business metrics to secure investor capital.
According to federal prosecutors, Raz raised approximately $27 million for Joonko by convincing investors that the company possessed a robust roster of corporate clients and impressive revenue streams that never actually existed. When an institutional investor eventually pressed the CEO for documentation to substantiate these glowing figures, Raz did not come clean. Instead, she doubled down on the deception, transmitting a forged bank statement and completely fabricated purchase orders to maintain the illusion of commercial traction. Last month, those actions caught up with her in a federal courtroom, where she formally entered a guilty plea for securities fraud—a charge that carries a maximum sentence of 20 years in federal prison.
The fallout from the Joonko scandal extends far beyond a single failed enterprise. It has triggered a broader reckoning across the startup landscape regarding how founders pitch their companies and how aggressively investors are willing to pursue legal remedies when expectations collide with reality. Building a venture-backed business inherently requires a heavy dose of vision and salesmanship; founders must successfully sell investors on what their companies could become tomorrow, not merely what they are today. However, Raz’s case illustrates the severe personal stakes of misrepresenting a business’s actual achievements. Investors, bruised by a shifting macroeconomic climate and heightened scrutiny over tech valuations, are increasingly willing to take those claims to court rather than quietly write off their losses.
Data compiled by Cornerstone Research highlights this litigious shift. Plaintiffs filed 15 AI-related securities class actions in the first half of 2026 alone, a staggering velocity that nearly matches the 16 cases filed throughout the entirety of 2025. This surge underscores a critical reality for early-stage and growth-stage companies: the legal distinction between future potential and present-day facts matters immensely. When describing customers, revenue, and market traction to prospective backers, precision is no longer optional.
Where “Puffery” Crosses the Line Into Securities Fraud
In the high-stakes arena of venture capital fundraising, distinguishing between harmless entrepreneurial hyperbole and actionable fraud is vital. The fundamental issue is not whether a pitch sounds optimistic, ambitious, or forward-looking, but whether its factual claims mislead investors in a material way. Knowingly misrepresenting performance metrics that directly influence an investor’s allocation decision can expose a founder to direct personal liability.
Legally, the question frequently boils down to the concept of materiality—specifically, whether a reasonable investor would consider the disputed information important when deciding whether to commit capital. To be clear, an inaccurate financial figure or a missed projection does not automatically establish securities fraud. Businesses stumble, forecasts fail, and market conditions shift. However, definitive false claims regarding active customer contracts, recurring revenue generation, or client retention rates cross a dangerous legal threshold. Such misrepresentations can expose founders to civil securities-fraud claims, and in the most egregious cases, criminal prosecution.
An ambitious growth forecast is one thing; a demonstrably false claim regarding existing customers or cash flow is entirely another. While founders often rely on corporate protections to shield themselves from operational missteps, the latter category can expose them personally, with no guarantee that corporate indemnification or insurance will cover the fallout.
Where D&O Coverage May Stop
When startup executives face investor lawsuits or regulatory scrutiny, they typically look to their directors and officers, or D&O, insurance policies for financial protection. However, mounting a defense against fraud allegations is fundamentally different from covering standard operational liabilities or management missteps. The precise wording of an insurance policy, alongside applicable federal and state laws, ultimately dictates where protection begins and ends.
The complexities of insurance coverage in high-profile fraud cases were highlighted by the legal maneuvers surrounding Joonko. As part of a court-approved settlement agreement, Raz reportedly agreed to abandon claims against the company’s D&O policies. While that particular agreement brought closure to certain aspects of the corporate wind-down, it left lingering questions regarding whether an insurer had previously funded her legal defense or ultimately denied coverage altogether as the extent of the fabrication came to light.
When evaluating risk, founders and corporate boards must pay close attention to several critical insurance policy provisions. Most standard D&O policies include exclusions for intentional fraudulent acts or deliberate criminal conduct. While insurers may initially advance defense costs while litigation is ongoing, they frequently retain the legal right to claw back those advanced funds if a court establishes that intentional fraud occurred. Furthermore, severability provisions within a policy dictate whether the knowledge or fraudulent acts of one executive can be imputed to other innocent members of the management team or the company itself, potentially jeopardizing coverage for the entire enterprise.
D&O insurance can provide a vital lifeline for founders navigating contentious investor disputes, but it is not a guaranteed backstop for established fraud. Founders must understand the exact mechanisms governing when coverage can terminate and whether they might be personally on the hook to reimburse their insurer for legal fees if allegations of deliberate deception are proven.
Navigating Metrics and Due Diligence
To mitigate these severe legal risks, founders must institute rigorous internal controls well before stepping into a pitch meeting. Before sharing a pitch deck with prospective investors, management teams should establish clear, internally consistent definitions for every metric utilized in their presentations. This involves spelling out precisely what constitutes a paying customer, how pilot programs and letters of intent are classified, and how metrics such as monthly recurring revenue and customer churn are calculated.
Connecting material claims to verifiable supporting records is equally essential. Founders should partner closely with their finance and legal advisers to ensure that every metric presented in a fundraising deck is backed by executed contracts, valid invoices, reliable accounting data, and up-to-date customer-status reports. Financial projections must be kept strictly separate from current operational results, with the underlying assumptions clearly documented.
Furthermore, management teams must avoid conflating distinct financial concepts. Annual recurring revenue, or ARR, and actual cash collected do not belong in the same category and should never be used interchangeably. Founders must clearly demonstrate how recurring revenue is calculated and distinguish it from one-time implementation fees, speculative pipeline opportunities, and contracted commitments that have not yet gone live. Similarly, contracted ARR must be treated as a separate metric from recognized ARR.
Finally, figures should be consistently dated, and material changes must be updated before investors rely on them to make investment decisions. If a team cannot easily explain the exact math behind a key performance indicator or substantiate a high-profile customer claim, that discrepancy must be resolved before the pitch deck leaves the conference room. Investors may ultimately buy into a founder’s ambitious vision for the future, but regulators and courts will always look strictly at the math.
